Home Medicine Ameliorative effect of gallic acid on doxorubicin-induced cardiac dysfunction in rats
Article
Licensed
Unlicensed Requires Authentication

Ameliorative effect of gallic acid on doxorubicin-induced cardiac dysfunction in rats

  • Temiday O. Omóbòwálé , Ademola A. Oyagbemi EMAIL logo , Ayorinde M. Folasire , Temitayo O. Ajibade , Ebunoluwa R. Asenuga , Olumuyiwa A. Adejumobi , Olufunke E. Ola-Davies , Orotusin Oyetola , Gana James , Adeolu A. Adedapo and Momoh A. Yakubu
Published/Copyright: October 9, 2017

Abstract

Background:

The use of doxorubicin (DOX) as an antineoplastic agent has been greatly limited because of the myriad of toxic sequelae associated with it. The aim of this study was to assess the protective effects of gallic acid (GA) on DOX-induced cardiac toxicity in rats.

Methods:

Sixty male rats (Wistar strain) were used in this study. They were divided into six groups (A–F) each containing 10 animals. Group A was the control. Rats in Groups B, C, and D were treated with DOX at the dosage of 15 mg/kg body weight i.p. Prior to this treatment, rats in Groups C and D had been treated orally with GA for 7 days at the dosage of 60 and 120 mg/kg, respectively. Animals from Groups E and F received only 60 and 120 mg/kg GA, respectively, which were administered orally for 7 days.

Results:

The exposure of rats to DOX led to a significant (p<0.05) decrease in the cardiac antioxidant defence system and elevation of creatine kinase myocardial band and lactate dehydrogenase. The electrocardiography results showed a significant decrease in heart rate, QRS, and QT-segment prolongation. GA alone improved the antioxidant defence system.

Conclusions:

The GA pretreatment significantly alleviated GA-associated ECG abnormalities, restored the antioxidant status and prevented cardiac damage.


Corresponding author: Dr. Ademola A. Oyagbemi, DVM, PhD, FCVSN, Department of Veterinary Physiology and Biochemistry, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria, Phone: +234833639776, Fax: +028103043; email:

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organisation(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Räsänen M, Degerman J, Nissinen TA, Miinalainen I, Kerkelä R, Siltanen A, et al. VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection. Proc Natl Acad Sci USA 2016;113:13144–9.10.1073/pnas.1616168113Search in Google Scholar

2. Klippstein R, Bansal SS, Al-Jamal KT. Doxorubicin enhances curcumin’s cytotoxicity in human prostate cancer cells in vitro by enhancing its cellular uptake. Int J Pharm 2016;514:169–75.10.1016/j.ijpharm.2016.08.003Search in Google Scholar PubMed

3. Prysyazhna O, Burgoyne JR, Scotcher J, Grover S, Kass D, Eaton P. Phosphodiesterase 5 inhibition limits doxorubicin-induced heart failure by attenuating protein kinase G Iα oxidation. J Biol Chem 2016;291:17427–36.10.1074/jbc.M116.724070Search in Google Scholar PubMed

4. Keeney JT, Miriyala S, Noel T, Moscow JA, St Clair DK, Butterfield DA. Superoxideinduces protein oxidation in plasma and TNF-α elevation in macrophage culture: insights into mechanisms of neurotoxicity following doxorubicin chemotherapy. Cancer Lett 2015;367:157–61.10.1016/j.canlet.2015.07.023Search in Google Scholar PubMed

5. Kwatra M, Kumar V, Jangra A, Mishra M, Ahmed S, Ghosh P, et al. Ameliorative effect of naringin against doxorubicin-induced acute cardiac toxicity in rats. Pharm Biol 2016;54:637–47.10.3109/13880209.2015.1070879Search in Google Scholar PubMed

6. Injac R, Boskovic M, Perse M, Koprivec-Furlan E, Cerar A, Djordjevic A, et al. Acute doxorubicin nephrotoxicity in rats with malignant neoplasm can be successfully treated with fullerenol C60(OH)24 via suppression of oxidative stress. Pharmacol Rep 2008;60:742–9.10.1016/S1734-1140(09)70041-6Search in Google Scholar PubMed

7. Thandavarayan RA, Watanabe K, Sari FR, Ma M, Lakshmanan AP, Giridharan VV, et al. Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice. Free Radic Biol Med 2010;49:1422–31.10.1016/j.freeradbiomed.2010.08.005Search in Google Scholar PubMed

8. Nakai S. Myriophyllum spicatum- released allelopathic polyphenols inhibiting growth of blue-green algae Microcystis aeruginosa. Water Res 2000;34:3026–32.10.1016/S0043-1354(00)00039-7Search in Google Scholar

9. Kim SH, Jun CD, Suk K, Choi BJ, Lim H, Park S, et al. Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol Sci 2006;91:123–31.10.1093/toxsci/kfj063Search in Google Scholar PubMed

10. Akinrinde AS, Oyagbemi AA, Omobowale TO, Asenuga ER, Ajibade TO. Alterations in blood pressure, antioxidant status and caspase 8 expression in cobalt chloride-induced cardio-renal dysfunction is reversed by ocimum gratissimum and Gallic acid in Wistar rats. J Trace Elem Med Biol 2016;36:27–37.10.1016/j.jtemb.2016.03.015Search in Google Scholar PubMed

11. Oyagbemi AA, Omobowale TO, Saba AB, Olowu ER, Dada RO, Akinrinde AS. Gallic acid ameliorates cyclophosphamide-induced neurotoxicity in wistar rats through free radical scavenging activity and improvement in antioxidant defense system. J Diet Suppl 2016;13:402–19.10.3109/19390211.2015.1103827Search in Google Scholar PubMed

12. Calderon A, Barrios V, Escobar C, Ferrer E, Barrios S, González-Pedel V, et al. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the sara study. Clin Exp Hypertens 2010;32:145–53.10.3109/10641960903254455Search in Google Scholar PubMed

13. Green LC, Ruiz de Luzuriaga K, Wagner DA. Nitrate biosynthesis in man. Proc Natl Acad Sci USA 1981;78:7764–8.10.1073/pnas.78.12.7764Search in Google Scholar

14. Crespo E, Macías M, Pozo D, Escames G, Martín M, Vives F, et al. Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB J 1999;13:1537–46.10.1096/fasebj.13.12.1537Search in Google Scholar PubMed

15. Xia Y, Zweier JL. Measurement of myeloperoxidase in leukocyte-containing tissues. Anal Biochem 1997;245:93–6.10.1006/abio.1996.9940Search in Google Scholar PubMed

16. Sinha KA. Colorimetric assay of catalase. Anal Biochem 1972;47:389–94.10.1016/0003-2697(72)90132-7Search in Google Scholar PubMed

17. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247:3170–5.10.1016/S0021-9258(19)45228-9Search in Google Scholar

18. Oyagbemi AA, Omobowale TO, Akinrinde AS, Saba AB, Ogunpolu BS, Daramola O. Lack of reversal of oxidative damage in renal tissues of lead acetate-treated rats. Environ Toxicol 2015;30:1235–43.10.1002/tox.21994Search in Google Scholar PubMed

19. Omobowale TO, Oyagbemi AA, Akinrinde AS, Saba AB, Daramola OT, Ogunpolu BS, et al. Failure of recovery from lead induced hepatoxicity and disruption of erythrocyte antioxidant defence system in wistar rats. Environ Toxicol Pharmacol 2014;37:1202–11.10.1016/j.etap.2014.03.002Search in Google Scholar PubMed

20. Habig, WH, Pabst, MJ, Jacoby WB. Glutathione-S-transferase activity: the enzymic step in mercapturic acid formation. J Biol Chem 1974;249:7130–9.10.1016/S0021-9258(19)42083-8Search in Google Scholar

21. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882–8.Search in Google Scholar PubMed

22. Gay CA, Gebicki JM. Measurement of protein and lipid hydroperoxides in biological systems by the ferric-xylenol orange method. Anal Biochem 2003;315:29–35.10.1016/S0003-2697(02)00606-1Search in Google Scholar PubMed

23. Olszewska-Słonina DM, Mątewski D, Czajkowski R, Olszewski KJ, Woźniak A, et al. The concentration of thiobarbituric acid reactive substances (TBARS) and paraoxonase activity in blood of patients with osteoarthrosis after endoprosthesis implantation. Med Sci Monit 2011;17:CR498–504.10.12659/MSM.881936Search in Google Scholar PubMed

24. Wendel A, Fausel M, Safayhi H, Tiegs G, Otter R. A novel biologically active seleno-organic compound-II, activity of PZ 51 in relation to glutathione peroxidase. Biochem Pharmacol 1984;33:3200–41.10.1016/0006-2952(84)90084-4Search in Google Scholar

25. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70–7.10.1016/0003-9861(59)90090-6Search in Google Scholar PubMed

26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265–75.10.1016/S0021-9258(19)52451-6Search in Google Scholar PubMed

27. Drury RA, Wallington EA, Cancerson R. Caltons histological techniques, 4th ed. UK: Oxford University Press, 1976.Search in Google Scholar

28. Menna P, Salvatorelli E, Minotti G. Anthracycline degradation in cardiomyocytes: a journey to oxidative survival. Chem ResToxicol 2010;23:6–10.10.1021/tx9003424Search in Google Scholar PubMed

29. You BR, Kim SZ, Kim SH, Park WH. Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis. Food Chem Toxicol 2010;48:1334–40.10.1016/j.fct.2010.02.034Search in Google Scholar PubMed

30. Ammar El-Sayed M, Shehta AS, Sally LE, Ghada MS. Cardioprotective effect of grape-seed proanthocyanidins on doxorubicin-induced cardiac toxicity in rats. Pharm Biol 2013;51:339–44.10.3109/13880209.2012.729065Search in Google Scholar PubMed

31. Padma VV, Poornima P, Prakash C, Bhavani R. Oral treatment with gallic acid and quercetin alleviates lindane-induced cardiotoxicity in rats. Can J Physiol Pharmacol 2013;91:134–40.10.1139/cjpp-2012-0279Search in Google Scholar PubMed

32. Chen R, Wang J, Zhang Y, Tang S, Zhan S. Key factors of susceptibility to antituberculosis drug-induced hepatotoxicity. Arch Toxicol 2015;89:883–97.10.1007/s00204-015-1473-1Search in Google Scholar PubMed

33. Beyerle J, Frei E, Stiborova M, Habermann N, Ulrich CM. Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer. Drug Metab Rev 2015;47:199–21.10.3109/03602532.2014.996649Search in Google Scholar PubMed

34. Nowakowska A, Tarasiuk J. Comparative effects of selected plant polyphenols, gallic acid and epigallocatechin gallate, on matrix metalloproteinases activity in multidrug resistant MCF7/DOX breast cancer cells. Acta Biochim Pol 2016;63:571–5.10.18388/abp.2016_1256Search in Google Scholar PubMed

35. Panchuk RR, Lehka LV, Terenzi A, Matselyukh BP, Rohr J, Jha AK, et al. Rapid generation of hydrogen peroxide contributes to the complex cell death induction by the angucycline antibiotic landomycin E. Free Radic Biol Med 2017;106:134–47.10.1016/j.freeradbiomed.2017.02.024Search in Google Scholar PubMed PubMed Central

36. Elberry AA, Abdel-Naim AB, Abdel-Sattar EA, Nagy AA, Mosli HA, Mohamadin AM, et al. Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats. Food Chem Toxicol 2010;48:1178–84.10.1016/j.fct.2010.02.008Search in Google Scholar PubMed

37. Davies MJ. Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention. J Clin Biochem Nutr 2011;48:8–19.10.3164/jcbn.11-006FRSearch in Google Scholar PubMed PubMed Central

38. Shah SL, Mali VR, Zambare GN, Bodhankar SL. Cardioprotective activity of methanol extract of fruit of Trichosanthes cucumerina on doxorubicin-induced cardiotoxicity in Wistar rats. Toxicol Int 2012;19:167–72.10.4103/0971-6580.97218Search in Google Scholar PubMed PubMed Central

39. Shivakumar P, Rani MU, Reddy AG, Anjaneyulu Y. A study on the toxic effects of Doxorubicin on the histology of certain organs. Toxicol Int 2012;19:241–4.10.4103/0971-6580.103656Search in Google Scholar PubMed PubMed Central

40. Patel SS, Goyal RK. Cardioprotective effects of gallic acid in diabetes-induced myocardial dysfunction in rats. Pharmacog Res 2011;3:239–45.10.4103/0974-8490.89743Search in Google Scholar PubMed PubMed Central

Received: 2016-12-27
Accepted: 2017-7-23
Published Online: 2017-10-9
Published in Print: 2018-1-26

©2018 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Behavior and Neuroprotection
  3. Seizure vulnerability and anxiety responses following chronic co-administration and acute withdrawal of caffeine and ethanol in a rat model
  4. Cardiovascular Function
  5. Indexes of the erythropoietin level in the blood plasma of chronic heart failure patients with anemia
  6. Oxidative Stress
  7. Ameliorative effect of gallic acid on doxorubicin-induced cardiac dysfunction in rats
  8. Sildenafil, a phosphodiesterase-5 inhibitor, offers protection against carbon tetrachloride-induced hepatotoxicity in rat
  9. Metabolism
  10. Antidiabetic potential of polyphenolic-rich fraction of Tamarindus indica seed coat in alloxan-induced diabetic rats
  11. Effect of L-carnitine on diabetes-induced changes of skeletal muscles in rats
  12. Inflammation
  13. Swimming, but not vitamin E, ameliorates prothrombotic state and hypofibrinolysis in a rat model of nonalcoholic fatty liver disease
  14. Infection
  15. In vitro ovicidal activity of poly lactic acid curcumin-nisin co-entrapped nanoparticle against Fasciola spp. eggs and its reproductive toxicity
  16. Phytotherapy
  17. Assessment of the antioxidant, thrombolytic, analgesic, anti-inflammatory, antidepressant and anxiolytic activities of leaf extracts and fractions of Tetracera sarmentosa (L.) Vahl
  18. Anti-invasive and antiproliferative effects of Pleurotus ostreatus extract on acute leukemia cell lines
  19. Letter to the Editor
  20. Is antiarrhythmic drug effectiveness stable? Extrapolating ICD in different space weather conditions
  21. Acknowledgment
Downloaded on 21.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2016-0194/html
Scroll to top button